Biotech developing AI-powered, botanically inspired neuroplastogens for mental health disorders
Entheos Labs is a Boston-based biotechnology company discovering and developing novel, botanically inspired neuroplastogens to treat mood, anxiety, trauma-based and substance use disorders. Founded in 2022 by Dr. Jerry Rosenbaum and Tristan Edwards, the company works in collaboration with Massachusetts General Hospital and uses AI to identify new chemical entities from overlooked natural psychedelic materials, including lead candidate ET-01. Its team combines pharmaceutical executives with scientific advisors from institutions such as Imperial College London and UCSF.
